Smart science to improve lives™

Indonesia

With a presence in Indonesia for more than a decade, our well-established office in the heart of Jakarta enables us to stay close to customers. We also established a world-class manufacturing site in Cikarang, Jababeka Industrial Estate in 1996, 50km from Jakarta. In addition to working with customers on product developments to meet unique requirements, our employees support the local community through active participation in the Croda 1% Club.

PT Croda Trading Indonesia

Cibis 9
17th Floor
Jl. Tb Simatunpang
No.2
Jakarta Selatan 12560
Indonesia
Tel: +62 21 759 0511PT 

PT Iberchem Indonesia Fragrances

Pusat Niaga Terpadu
JI. Daan Mogot Raya Km 19,6 Blok GG8N
15122 Tangerang
Indonesia
T +62 21 54397722
T +62 21 54396622
Cikarang team in Indonesia group shot.
close up of test tubes in croda lab

Croda at a glance

At Croda, we are driven by our Purpose, to use smart science to create high-performance ingredients and technologies that improve lives.

Croda Formulator at work in labs

Where we operate

Every day our global team, across 37 countries, work together to inspire our customers.

Further reading

U.S. Government to support expansion of Croda lipid systems capability

Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines

Read more

Sustainability expert Aris Vrettos joins Croda

The new position will see the sustainability expert challenge Croda to stretch its already industry-leading sustainability ambitions and commitments and support Croda’s business sectors in further...

Read more

Croda joins the World Business Council for Sustainable Development

Croda International Plc, the company that uses smart science to create high-performance ingredients and solutions that improve lives, has today joined over 200 of the world’s leading sustainable...

Read more
Laboratory work

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

Read more